With the emergency use authorization for its COVID-19 drug Lagevrio ending and no new drug approval expected before the deadline, Merck faces the operational challenge of winding down the product in the U.S. and managing a future revenue gap.
Filing excerpt
On June 29, 2026, the Secretary of HHS determined that circumstances no longer exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic and provided advance notice that the declaration supporting the EUA for Lagevrio will terminate, effective June 29, 2027.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qmajorContractLossGet every 10-Q signal for Merck and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/1782d554-4f08-41de-8161-d78b05fd1878 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.
{
"signal_id": "1782d554-4f08-41de-8161-d78b05fd1878",
"signal_type": "sec-10q",
"signal_subtype": "majorContractLoss",
"detected_at": "2026-08-11T08:11:50.628+00:00",
"company": {
"name": "Merck",
"domain": "merck.com"
},
"data": {
"detail": "With the emergency use authorization for its COVID-19 drug Lagevrio ending and no new drug approval expected before the deadline, Merck faces the operational challenge of winding down the product in the U.S. and managing a future revenue gap.",
"summary": "Lagevrio COVID-19 drug EUA to terminate in June 2027, creating revenue gap and operational challenges.",
"excerpts": "On June 29, 2026, the Secretary of HHS determined that circumstances no longer exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic and provided advance notice that the declaration supporting the EUA for Lagevrio will terminate, effective June 29, 2027.",
"relevance": 0.85,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm",
"filing_date": "2026-08-07",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Urgency to improve",
"signal_category": "revenue",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/1782d554-4f08-41de-8161-d78b05fd1878 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.